🇩🇪 UMECLIDINIUM BROMIDE in Germany

UMECLIDINIUM BROMIDE (UMECLIDINIUM BROMIDE) regulatory status in Germany.

Marketing authorisation

BfArM

  • Local brand name: Incruse Ellipta (previously Incruse)
  • Status: approved

UMECLIDINIUM BROMIDE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is UMECLIDINIUM BROMIDE approved in Germany?

Yes. BfArM has authorised it.

Who is the marketing authorisation holder for UMECLIDINIUM BROMIDE in Germany?

Marketing authorisation holder not available in our data.